FACTBOX-Price estimates for Gilead's remdesivir for COVID-19 - Reuters

11:36am PDT - June 24th, 2020    remdesivir - Reuters

The potential U.S. pricing of Gilead Sciences Inc's antiviral remdesivir, among the first drugs shown to be effective against COVID-19, has been a highly debated topic among investors and analysts. What Gilead could charge for remdesivir after its pledge…